IP Library Granted Patent US 11,702,433
Granted Patent B2
US 11,702,433 · App. 16/601,022 · Granted Jul 18, 2023

Functionalized F-POSS monomer compositions and uses thereof

Inventors: John C. Warner (Wilmington, MA); Jean R. Loebelenz (Essex, MA); Srinivasa Rao Cheruku (Lexington, MA); Thomas Woodrow Gero (Stow, MA); Perry L. Catchings, Sr. (Roxbury, MA)
Assignee: NBD NANOTECHNOLOGIES, INC.
C07F7/21C08G77/045C08G77/24C08K5/549C08L83/04C09D7/62C09D183/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,702,433
App. No.
16/601,022
Granted
Jul 18, 2023
Kind
B2
Abstract

Functionalized F-POSS compounds comprising synthetic blends of at least two feedstocks that produce a distribution of fluorinated polyhedral oligomeric silsesquioxane molecule structures and/or functional groups.

Claims (28)

1. An article comprising a synthetic blend copolymer prepared by polymerization of a compound having a formula I

wherein,

R 1 is a long chain fluorinated alkyl that is a straight chain or a branched chain alkyl group having 5 to 12 carbon atoms in a longest continuous chain of carbon atoms as counted from a point of attachment of the longest continuous chain of carbon atoms to a silicon atom at any apex of a silicon-oxide core, where at least one hydrogen atom in the straight chain or the branched chain alkyl group is replaced by a fluorine atom;

R 2 is selected from the group consisting of C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic and 5-7 membered heteroaryl, wherein each hydrogen atom in R 2 is independently optionally substituted by an R 3 ;

R 3 is —OC(O)R 4 or —OC(O)OR 4 ;

R 4 is methyl, wherein each hydrogen atom in R 4 is independently optionally substituted by an R 6 ;

each R 6 is independently selected from the group consisting of halo, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic, 5-7 membered heteroaryl, —NCO, —OR 7 , —NR 7 R 8 , —OC(O)R 7 , —C(O)OR 7 , —C(O)R 7 , —OC(O)OR 7 , —C(O)NR 7 R 8 , —OC(O)NR 7 R 8 , —NR 7 C(O)R 8 , —NR 7 C(O)OR 8 and —NR 7 C(O)NR 7 R 8 , and when R 6 is C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic or 5-7 membered heteroaryl, each hydrogen atom in R 6 is independently optionally substituted by an R 9 ;

each R 7 and R 8 is independently selected from the group consisting of hydrogen, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic and 5-7 membered heteroaryl, wherein each hydrogen atom in R 7 and R 8 is independently optionally substituted by one or more R 9 ;

each R 9 is independently selected from the group consisting of hydrogen, halo, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic, 5-7 membered heteroaryl, —NCO, —OR 10 , —NR 10 R 11 , —OC(O)R 10 , —C(O)OR 10 , —C(O)R 10 , OC(O)OR 10 , —C(O)NR 10 R 11 , —OC(O)NR 10 R 11 , —NR 10 C(O)R 11 , —NR 10 C(O)OR 11 and NR 10 C(O)NR 10 R 11 , and when R 9 is C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl, C 3 -C 8 cycloalkyl, 5-7 membered heterocyclic, C 3 -C 8 cycloalkyl or 5-7 membered heteroaryl, each hydrogen in R 9 is independently optionally substituted by a moiety selected from the group consisting of halo, —NCO, —OR 10 , —NR 10 R 11 , —OC(O)R 10 , —C(O)OR 10 , —C(O)R 10 , OC(O)OR 10 , C(O)NR 10 R 11 , —OC(O)NR 10 R 11 , —NR 10 C(O)R 11 , —NR 10 C(O)OR 11 and NR 10 C(O)NR 10 R 11 ;

each R 10 and R 11 is independently selected from the group consisting of H, C 1 -C 8 alkyl, C 2 -C 8 alkenyl and C 2 -C 8 alkynyl, and when R 10 or R 11 are C 1 -C 8 alkyl, C 2 -C 8 alkenyl or C 2 -C 8 alkynyl, each hydrogen atom in R 10 and R 11 is independently optionally substituted by a fluorine atom;

n is an integer from 1 to 7; and,

each R 10 and R 11 is independently covalently attached at a silicon atom,

with at least one monomer; wherein the compound of the formula I is prepared by a process comprising:

(a) contacting a compound of the formula R 1 Si(OR A ) 3 with a compound of the formula R 2 Si(OR A ) 3 , in the presence of a base, wherein —OR A is a C 1 -C 8 alkoxy, and the —OR A on R 1 Si(OR A ) 3 and R 2 Si(OR A ) 3 can be the same or different.

2. The article of claim 1 , wherein R 2 is C 1 -C 8 alkyl, wherein each hydrogen atom in R 2 is independently optionally substituted by an R 3 .

3. The article of claim 1 , wherein R 3 is —OC(O)R 4 .

4. The article of claim 1 , wherein each hydrogen atom in R 4 is independently optionally substituted by C 2 -C 8 alkenyl.

5. The article of claim 1 , wherein R 6 is C 1 -C 8 alkyl, —NCO, —OR 7 , —NR 7 R 8 , —OC(O)R 7 , C(O)OR 7 , —C(O)R 7 or —OC(O)OR 7 .

6. The article of claim 1 , wherein R 7 is C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 6 -C 10 aryl or 5-7 membered heteroaryl, wherein each hydrogen atom in R 7 is independently optionally substituted by one or more R 9 .

7. The article of claim 1 , wherein R 9 is hydrogen or C 1 -C 8 alkyl, and when R 9 is C 1 -C 8 alkyl, R 9 is optionally substituted by a —OC(O)R 10 .

8. The article of claim 1 , wherein R 10 is H or C 1 -C 8 alkyl, and when R 10 is C 1 -C 8 alkyl, each hydrogen atom in R 10 is independently optionally substituted by a fluorine atom.

9. The article of claim 1 , wherein R 2 is n-propyl, wherein each hydrogen atom in R 2 is independently optionally substituted by an R 3 .

10. The article of claim 9 , wherein each hydrogen atom in R 4 is independently optionally substituted by —CH═CH 2 .

11. The article of claim 1 , wherein R 3 is —OC(O)R 4 —.

12. The article of claim 1 , wherein the base is potassium hydroxide or tetraethylammonium hydroxide.

13. The article of claim 12 , wherein the long chain fluorinated alkyl is 8/2, 6/2 or 4/2.

14. The article of claim 1 , wherein the monomer is an acrylate.

15. The article of claim 14 , wherein the acrylate is methacrylate or methylmethacrylate.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2023
From: NBD NANOTECHNOLOGIES INC.
To: HENKEL AG & CO. KGAA
Reel/Frame 065406/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2020
From: WARNER, JOHN C; LOEBELENZ, JEAN R; CHERUKU, SRINIVASA RAO; GERO, THOMAS WOODROW; CATCHINGS, PERRY L, SR
To: NBD NANOTECHNOLOGIES, INC.
Reel/Frame 054683/0707 →
Continuity (7)
Division 15705089 · Sep 14, 2017
Continuation In Part 15230697 · Aug 8, 2016
Continuation In Part 15065289 · Mar 9, 2016
Continuation 14876911 · Oct 7, 2015
Provisional Application 62130170 · Mar 9, 2015
Provisional Application 62060622 · Oct 7, 2014
Related Publication 20200040016A1 · Feb 6, 2020